Stage III Ovarian Cancer

specific

Stage III includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. T3a: Ovarian cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Ovarian cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm

36

Centers

19

Active Trials

—

Cancer Funding

Top Centers for Stage III Ovarian Cancer(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
High-Volume Research Center
73.3
2
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
Active Research Program
62.6
3
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
62.6
4
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
62.6
5
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
62.6
6
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
62.6
7
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
62.6
8
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
62.6
9
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
62.6
10
Hollings Cancer CenterCharleston, SC
NCI Clinical
Active Research Program
62.6
11
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
62.6
12
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
62.6
13
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
62.6
14
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
62.6
15
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
62.6
16
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
62.6
17
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
62.6
18
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
40.8
19
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
40.8
20
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
40.8
21
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
40.8
22
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
40.8
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
40.8
24
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
40.8
25
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
40.8
26
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
40.8
27
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
40.8
28
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
40.8
29
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
40.8
30
University of Illinois Cancer CenterChicago, IL
40.8
31
Boston University Cancer CenterBoston, MA
40.8
32
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
40.8
33
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
40.8
34
Cancer Center at IllinoisUrbana, IL
40.8
35
Stony Brook Cancer CenterStony Brook, NY
40.8
36
Princess Margaret Cancer CentreToronto, ON
40.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →